Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
08 nov 2006 - 14:18
Statutaire naam
Crucell N.V.
Titel
DSM and Crucell Celebrate Opening of PERCIVIA PER.C6® Development Center in Cambridge, Mass.
Bericht
Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) and technology partner DSM Biologics, a business unit of DSM Pharmaceutical Products announced today the opening of the PERCIVIA PER.C6® Development Center, a product of an earlier announced joint venture between the two Dutch companies. The official opening ceremonies will take place at the PER.C6® Development Center (1 Hampshire Street, Cambridge, Mass.) on Tuesday, November 14 at 11 a.m.
Datum laatste update: 04 februari 2026